FDA chief has been confirmed despite concerns over his pharmaceutical industry ties

France Nouvelles Nouvelles

FDA chief has been confirmed despite concerns over his pharmaceutical industry ties
France Dernières Nouvelles,France Actualités
  • 📰 KPBSnews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

The Senate voted on Tuesday to confirm Dr. Robert Califf to head the FDA on a 50-46 vote. The agency has been without a permanent leader for the last 13 months.

Dr. Robert Califf testifies before a Senate Committee on Health, Education, Labor and Pension hearing on the nomination to be commissioner of Food and Drug Administration on Dec. 14, 2021.

Dr. Robert Califf will once again head the Food and Drug Administration, narrowly securing his position as the head of the consumer safety agency. The Senate confirmed Califf on Tuesday despite some concerns over his close ties to the pharmaceutical industry and GOP opposition to his stance on access to birth control.Six Republicans — Sens.

Independent Sen. Bernie Sanders voted against Califf's confirmation, joining Democratic Sens. Richard Blumenthal, Maggie Hassan, Joe Manchin and Ed Markey.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

KPBSnews /  🏆 240. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Senate confirms Robert Califf, President Joe Biden’s FDA pick, despite political divisionsSenate confirms Robert Califf, President Joe Biden’s FDA pick, despite political divisionsThe Senate narrowly confirmed President Joe Biden’s pick to lead the Food and Drug Administration on Tuesday pushing past a thicket of political controversies that threatened to derail what was initially expected to be an easy confirmation.
Lire la suite »

New FDA program could boost drug development for rare diseasesNew FDA program could boost drug development for rare diseasesThe FDA and pharmaceutical companies want to improve drug development and approval for rare diseases, the majority of which lack approved treatments. There are over 7,000 rare diseases in the U.S. and only about 5% to 6% have FDA-approved treatments.
Lire la suite »



Render Time: 2025-04-12 18:10:28